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Abstract 
Age is associated with decrease in several cognitive functions whereof some changes may 
indicate a beginning pathologic process resulting in a state of dementia. The papers included 
in the thesis addressed questions related to cognitive and olfactory changes in elderly 
individuals with an aim to gain knowledge on the influence of the Apolipoprotein E (ApoE) 
ε4 allele on cognition and to extend the understanding of the association between cognitive 
functioning and odor identification performance. The first paper investigated the impact of the 
ApoE ε4 allele on cognitive functioning in a sample of non demented elderly individuals 
recruited from a population with a high prevalence of this allele. Paper 2 addressed the 
question whether the Scandinavian Odor Identification Test (SOIT) and its cut-off scores for 
diagnosis (hyposmia and anosmia) is applicable and valid to be used in Norwegian samples of 
middle aged and older individuals. The occurrence of olfactory dysfunction was further 
investigated in the third paper. It was examined whether individuals who were unaware of an 
olfactory dysfunction performed lower on cognitive tasks compared to individuals with 
normal olfactory function. In paper 4, the interrelation between different odor identification 
tasks (familiarity, cued and free odor identification), their association with cognitive measures 
as well as age-related performance differences were investigated. The present thesis shows 
that deficits in cognitive performance, demonstrated in verbal learning and memory tasks, can 
be related to the ApoE ε4 allele. The papers on olfactory functioning revealed the 
applicability of the SOIT in the elderly segment of the Norwegian population. It was shown 
that olfactory dysfunction increases with age and that changes often remain unnoticed. 
Individuals unaware of their olfactory dysfunction performed lower on a number of cognitive 
measures. The ability to identify odors was associated with a varying number of cognitive 
measures depending on the demands of the task. In conclusion, this thesis strengthens the 
generality of previous findings demonstrating an association between ApoE ε4 and impaired 
performance on verbal learning and memory tasks. The findings indicate further that odor 
identification performance is associated with a number of cognitive measures, predominantly 
episodic memory functioning. Odor identification tasks may provide valuable information in 
the examination of elderly individuals at risk for pathological decline.  
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It is the enormous disparities in degree of mental decline observed among 
those in late and middle life that constitute the most powerful challenge. On 
the one hand, there are those exemplified by Casals, Picasso, Bertrand 
Russell, Verdi and Michelangelo: creative, intellectually vigorous, active and 
committed with the fire and intensity of youth to the values and causes that 
had inspired them throughout their lives. At the other extreme is the 
substantial proportion of those already in an advanced state of dementia at 70 
and some even in their 40s or 50s. It is the conviction that there must be 
causes definable by science underlying such disparities that inspires and 
sustains the efforts of those engaged in research in this field. Any success 
they achieve will contribute to freeing old age from the spectre of dying in a 
state of mental oblivion and so eliminate the worst scourge of the later years. 
     
Sir Martin Roth, British Medical Bulletin (1986) Vol. 42, pp. 42-50 
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INTRODUCTION 
Age is taking its toll on cognitive as well as sensory functions in human beings. 
Irrespective of whether these changes are due to the normal aging process or may indicate the 
beginning of a devastating neurodegenerative disease, they are of great importance in the 
individual’s life and for the society at large. A considerable proportion of elderly individuals 
will be affected by sporadic late-onset Alzheimer’s disease (AD), the most common form of 
dementia illnesses beyond the age of 65 years (Bachman et al., 1992). A definite diagnosis of 
AD can only be given at autopsy and the clinical diagnosis as well as the identification of the 
early changes relies so far heavily on alterations in neuropsychological test performance. In 
that the signs of early cognitive decline in patients with AD are heterogeneous and similar to 
what can be found in other types of neuropsychiatric disorders or may be attributed to be a 
part of the normal aging process, the collection of empirical evidence of possible markers for 
AD continues. 
The ε4 allele of the Apolipoprotein E (ApoE) gene is a well-established risk factor for 
AD. There are, however, open issues with regard to its relation to normal cognitive aging in 
varying populations. The objective of the first paper was to examine the influence of the ε4 
allele on cognitive performance in aging individuals coming from a population with a high 
frequency of the ε4 allele. Olfactory dysfunction occurs frequently in the elderly (Murphy et 
al., 2002). Lately, the clinical significance of an impairment to identify odors has increasingly 
been recognized as an important indicator for future cognitive decline and AD (Calhoun-
Haney & Murphy, 2005; Swan & Carmelli, 2002). This induced papers 2-4, investigating the 
applicability of an olfactory test (paper 2), and furthermore the association between odor 
identification abilities and cognitive functioning (paper 3 and 4) in healthy middle aged and 
older individuals. 
 
Cognitive aging 
Cross-sectional behavioral research demonstrates a life long linear decline beyond the 
age of 20 in several cognitive domains including mental processing speed, working memory 
measures (visuospatial and verbal), and long-term memory measures (visuospatial and verbal) 
(Park & Minear, 2006; Park et al., 1996, 2002). Longitudinal studies support these findings 
although results show that reductions often do not occur before an age of 60 years and that 
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large inter-individual variability may be found (Christensen et al., 1999; Wilson, Beckett, 
Bennett, Albert & Evans, 1999; Wilson et al., 2002). Evidence indicates further that age-
related decline is more pronounced in some cognitive domains including episodic and 
working memory function as well as perceptual speed, whereas minor changes have been 
found in semantic knowledge and vocabulary (Park et al., 2002). In further exploring age-
related differences in memory functioning, Nyberg et al. (2003) demonstrated that elderly 
individuals exhibit a greater decline in measures of recall compared to recognition in an 
episodic memory task. Based on these findings and similar ones from other studies, it has 
been suggested that age differences may become particular apparent in tasks demanding self-
initiated and effortful processing (Luo & Craik, 2008; Nyberg & Bäckman, 2004; Zacks & 
Hasher, 2006).   
A variety of mechanisms have been proposed to be responsible for the deterioration of 
cognitive functioning. A well-known proposal refers to mental processing speed: Salthouse 
(1996) argued that the reduction in processing speed occurring with age leads to declines in 
several cognitive functions, including memory. He suggested that memory performance was 
only indirectly and weakly influenced by age when processing speed was controlled for. 
However, this suggestion has been criticized since not all tasks demonstrating age-related 
declines have a speed component (e.g. free recall) (Luo & Craik, 2008). Other approaches 
have suggested that a decline in working memory capacity (Craik & Bryd, 1982), or 
inhibitory processing or executive functioning (Hasher & Zacks, 1988) are of importance to 
explain age-related decline in cognitive functioning. Alternatively, Lindenberger and Baltes 
(1994) showed that sensory functioning was an important factor in mediating age-related 
declines in a variety of cognitive tasks. They argued that reduced sensory functioning not by 
itself, but as an indicator for overall neurological health, could result in poor performance. 
 Neuroimaging studies have contributed to better understanding of associate behavioral 
and structural changes in aging by showing a general shrinkage in gross volume with age and 
alterations occurring in both grey and white matters. It has been demonstrated that some brain 
areas, particularly in the prefrontal cortex, undergo the largest volumetric changes (Raz, 2004) 
and that these areas seem particularly affected by alterations of white matter density and 
neurotransmitter level (Bartzokis, Cummings, Sultzer, Nuechterlein & Mintz, 2003; Head et 
al., 2004; Volkow et al., 2000). Studies using functional magnetic resonance imaging (fMRI) 
and positron emission tomography (PET) have repeatedly shown activation in areas of the 
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prefrontal cortex during episodic (encoding and retrieval) and working memory tasks (Cabeza 
& Nyberg, 2000), supporting a close relation between cognitive and structural changes. Other 
studies have shown that the hippocampus and the surrounding medial temporal cortex are 
important for episodic memory function (Nyberg, Cabeza & Tulving, 1996). However, it 
seems that the latter undergo only small age-related changes in normal aging individuals (Raz, 
2004).  
Thus, cognitive changes seen in normal aging individuals may often relate to changes 
occurring in the frontal areas of the brain. Luo and Craik (2008) suggested that multiple 
factors may account for age-related changes in cognitive function and that these factors may 
be interrelated. They suggest that differences in patterns of memory decline may provide 
important information to differentiate pathological (decline cause by a neurodegenerative 
disease such as AD) from normal aging. 
 
Neuropsychological characteristics of preclinical Alzheimer’s disease 
An immense number of studies has demonstrated that individuals who develop AD 
experience deficits in verbal episodic learning and memory function (Albert, Moss, Tanzi & 
Jones, 2001; Bondi, Salmon, Galasko, Thomas & Thal, 1999; Grober & Kawas, 1997), and 
that impairment may occur 6-10 years before an AD diagnosis is given (Bäckman, Small & 
Fratiglioni, 2001; Grober et al., 2008; Tierney, Yao, Kiss & McDowell, 2005). 
Although the progression of the neuropathological changes is not fully known, 
findings indicate that the decline in memory function parallels the neuropathological changes 
seen early in the AD disease process. Braak and Braak (1991) classified the development of 
intracellular changes into six stages. In stages I/II changes occur in the transentorhinal and 
entorhinal region of the temporal lobe, from where the pathologic process continues to the 
hippocampus and the temporal neocortex (stage III) and association areas of the adjoining 
neocortex (stage IV). The spreading then continues and covers finally the neocortex (stages V 
and VI).  
Despite the convincing findings that impaired memory function is a core characteristic 
of incipient AD, there is also substantial evidence that deficits in other cognitive domains, 
including executive functioning, verbal ability, visuospatial functioning, attention and 
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perceptual speed, are present during the prodromal phase of AD (Bäckman, Jones, Berger, 
Laukka & Small, 2005; Storandt, Grant, Miller & Morris, 2006). In a recent review including 
studies of nondemented cognitively normal individuals, Twamley, Ropachi and Bondi (2006) 
found that early signs of AD may be found in a wide range of cognitive domains (either by 
showing early decline in these domains or revealing significant differences between a control 
group and individuals at risk for AD). Based on results most consistently registering 
impairments of attention, followed in frequency by deficits in verbal learning and memory, 
executive functioning, processing speed, and language, the authors concluded that although 
there has been a predominant focus on episodic memory function, other makers will occur 
with the development and use of experimental paradigms. Combined with their review of 
neuroimaging data indicating volume loss and metabolic changes in the temporal lobe, the 
authors proposed a model for a distinct course of decline in episodic memory function in 
preclinical AD. They suggested that after an initial drop in performance, the impairment 
remains stable for a number of years before another period of accelerated decline occurs one 
or two years before diagnosis (Figure 1) (Bäckman et al., 2001; Bunce, Fratiglioni, Small, 
Winblad & Bäckman, 2004; Smith et al., 2007; Twamley et al., 2006).  
Some authors have suggested that the period of poor but stable memory impairment 
may be of clinical importance (Smith et al., 2007). They suggest that compensatory 
mechanisms such as neurotransmitter up-regulation or activation of broad neural networks 
may be activated to maintain the former performance level. According to this view, the 
decline may be slowed down for some time. When the additional activated resources are 
compromised in the course of the disease, eventually through the continuous pathological 
changes, this might finally result in rapid memory decline at a second point in time. Other 
authors suggest that the onset of clinical symptoms may further be influenced by factors such 
as level of education, intelligence, leisure activities, commonly referred to as cognitive 
reserve (Fratiglioni & Wang, 2007).   
The differential pattern of age-related changes in functioning (as described in the two 
previous sections) has induced the hypothesis that cognitive decline seen in aging individuals 
may be related to two distinguishable processes, one associated with normal cognitive aging, 
involving the prefrontal cortex, and one associated with pathological aging, related to 
alterations in medial temporal lobe functioning (Buckner, 2004; Hedden & Gabrieli, 2004). 
Thus, changes seen in normal aging associated with mild memory decline which can be 
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related to attention and executive functioning may be referred to changes in fronto-striatal 
systems.  Changes due to neurodegenerative processes, i.e. AD, affect areas in the medial 
temporal lobe, starting in the entorhinal cortex, leading directly to memory impairment. 
 
Preclinical Phase Clinical Phase
Year
-5 -4 -3 -2 -1 0 1 2
Mild and relatively stable memory
decline in the earlier preclinical period
Compensatory  mechanisms operating
Plaques and tangles forming,
neuron and synapse losses accruing
Severe and rapid memory
decline in the late
preclinical period
 
Figure 1: The figure, originally adapted from Twamley et al. (2006), shows the proposed 
nonlinear pattern of decline of episodic memory function during the preclinical phase of 
Alzheimer’s disease. 
 
Genetic factors in cognitive aging: the Apolipoprotein E 
The urge to understand the molecular basis of pathological cognitive aging and AD 
was reinforced by genetic research identifying the ApoE as an important gene for 
understanding AD (Strittmatter et al., 1993). ApoE is a cholesterol-transporting protein coded 
on chromosome 19 by a polymorphic gene with three allele types: ε2, ε3, and ε4. As 
individuals inherit one allele from each parent, six ApoE genotypes are possible: ε2ε2, ε2ε3, 
ε3ε3, ε2ε4, ε3ε4, ε4ε4. It has been shown that the presence of one ε4 allele (heterozygote) 
increases the risk of developing AD and that the risk further increases in a dose-dependent 
manner, i.e. individuals who have inherited two copies of the ε4 alleles (homozygote) have a 
greater risk than those with only one copy (Corder et al., 1993). Results demonstrate further 
  
15 
 
that AD symptoms may occur earlier in patients carrying at least one ε4 allele (Blacker et al., 
1997). 
In a large meta-analysis, Farrer et al. (1997) found that the risk of AD increases up to 
3 times in heterozygote carriers and up to 14 times in homozygote carriers compared to 
individuals carrying any of the other isoforms (all numbers reported here relate to studies 
including individuals of Caucasian origin, see below). In addition, the authors reported age 
and gender effects, indicating that the ε4 genotype was associated with an increased risk for 
AD between 40 and 70 years, thereafter diminishing. Gender effects were shown in that 
women were at higher risk for AD regardless of genotype and that the risk might further 
increase in women with the ε3/ε4 genotype. An important finding was that the association 
between ApoE ε4 and AD is apparently not uniform across all ethnic groups. That is, while 
the ε4 allele was found to be strongly related to the risk of AD in Caucasians, that association 
was inconsistent and weaker in Afro Americans and Hispanics. Other studies have 
corroborated these findings (Evans et al., 2003; Gureje et al., 2006; Maestre et al., 1995; Tang 
et al., 1998). 
The ApoE ε3 allele is the most common form, found in approximately 78% of the 
general population, whereas ε2 (7%) and ε4 (15%) are less common (Roses, 1996). There is 
however, a noteworthy peculiarity in the distribution of ApoE frequencies, indicating a south-
to-north gradient of the ε4 allele in Europe, with the proportion of ApoE ε4 carriers increasing 
from 10-15% in the south to 40-50% in the north (Figure 2; Gerdes, 2003). The functional 
consequences of this genetic variation have to be determined. So far, reviews have generally 
concluded that there is no geographic variation in the frequency of dementia (Hofman et al., 
1991; Rocca et al., 1991). However, one study reported higher incidence rates in the northern 
compared to the southern countries (Fratiglioni et al., 2000). These findings emphasize the 
need to investigate the effect of genetic makers in general and of ApoE in particular in 
different countries and populations. 
The neurobiological processes in the brain that account for the association of the ε4 
allele and the risk for AD are still not understood, but a number of hypotheses exist (Bales, 
Dodart, DeMattos, Holtzman, & Paul, 2002; Mahley, Weisgraber, & Huang, 2006). 
Neurofibrillary tangles and amyloid plaques, consisting of tau and beta amyloid peptides 
(Aβ), respectively, are the hallmarks of AD. The “amyloid hypothesis” suggests that ApoE ε4 
inhibits Aβ clearance and stimulates its extracellular deposition as well as enhances Aβ 
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production. Independent of Aβ, ApoE ε4 has been suggested to have an effect on the 
phosphorylation of the microtubule associated tau protein and thus contribute also to the 
formation of neurofibrillary tangle. These hypotheses are supported by post mortem studies of 
patients diagnosed with AD showing an increased density of neuritic plaques, amyloid 
deposition, and neurofibrillary tangles in ε4 carriers (Ghebremedhin et al., 2001; Polvikoski et 
al., 1995; Sparks et al., 1996).    
 
 
Figure 2: Proportion of individuals with the ApoE ε33 genotype and proportions of ApoE ε2 
and ApoE ε4 carriers in various European populations, as functions of latitude north (with 
permission from Gerdes, 2003). 
 
Another hypothesis links ApoE ε4 not explicitly to AD pathology, but to neuronal 
health in general. The “neuronal repair hypothesis” proposes that ApoE ε4 causes neurotoxity, 
as its fragments are translocated into the cytosol were they interact with cytoskeletal elements 
(microtubules and microfilaments) or mitochondria. According to the neuronal repair 
hypothesis, ApoE ε4 may be related to neuronal health and brain function throughout lifetime 
and not only to pathological processes in older age. This hypothesis finds support in studies 
examining the influences of ApoE isoforms on normal cognition. Flory, Manuck, Ferrell, 
Ryan, and Muldoon (2000) found that in a middle aged sample, ε4 carriers performed 
significantly lower on learning and memory tasks than non carriers, and Greenwood, 
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Sunderland, Friz, and Parasuraman (2000) found that ε4 carriers exhibited deficits of shifting 
in tests of visual attention. 
Despite the strong evidence of an association between ApoE ε4 and AD, it is 
important to note that it is possible to reach old age with normal cognition although being a 
carrier of the ε4 allele or conversely, to develop AD in the absence of the ε4 allele. 
 
Apolipoprotein ε4 and cognition  
Due to the findings in AD patients, efforts have been made to examine whether the ε4 
allele confers a risk for cognitive impairment in non demented older individuals. While 
several studies have found that carriers of the ε4 allele perform lower on cognitive tests than 
non demented older individuals that do not carry the ε4 allele (Bartez-Faz et al., 1999; Bondi 
et al., 1995; Caselli et al., 1999, 2001; Dik et al., 2000; Flory et al., 2000; Helkala et al., 1996; 
Mayeux, Small, Tang, Tycko, & Stern, 2001; O’Hara et al., 1998), other studies have failed to 
find such a significant difference (Bennet et al., 2005; Bondi et al., 1999; Bunce et al., 2004; 
Small et al., 2000; Smith et al., 1998). A possible explanation for these conflicting results 
could be that the studies showing a significant difference between ε4 carriers and non carriers 
might have included individuals who were in a preclinical phase of AD during assessment. 
For example, in a study by Bondi et al. (1999) the ε4-related differences on a memory task 
were significantly reduced when those participants who developed AD at follow up were 
removed from the sample. Thus, since ApoE is involved in pathological processes due to AD 
and since cognitive deficits may be present several years before a clinical diagnosis of AD is 
given, it is difficult to separate preclinical AD from cognitive impairment unrelated to AD. 
However, there may also be other reasons for the variability in results. Smith et al. 
(1998) found that ε4 carriers below the age of 80 years performed more poorly on delayed 
recall compared to non carriers whereas this pattern was reversed in individuals above the age 
of 80. Thus, the age-range included in studies seems to influence results. Other researchers 
have found that the type of cognitive tests applied may be of importance: Parasuraman, 
Greenwood, and Sunderland (2002) demonstrated that tests of spatial attention and working 
memory might be particularly sensitive to ε4 related impairments. Furthermore, sample 
characteristics such as the frequency of heterozygote and homozygote carriers or the sample 
size may contribute to results. In a meta-analysis, including cross-sectional studies on 
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cognitively intact older individuals, Small, Rosnick, Fratiglioni, and Bäckman (2004) 
concluded that the ε4 allele is associated with reduced global cognitive performance, episodic 
memory, and executive functioning, but that the ε4-related effect is rather modest. The 
authors argued further that the variability between findings seems to be a result of statistically 
significant but small differences between groups of ε4 carriers and non carriers, a specific 
impact of the ε4 genotype on certain cognitive domains as well as age- and zygosity-related 
factors.  
 
Mild cognitive impairment  
Recurring efforts have been made to define the boundary between cognitively normal 
aging and the prodromal phase of a clinically disclosed dementia (Collie & Marfuff, 2002; 
Tuokko & Hultsch, 2006). Among the concepts that have been proposed, mild cognitive 
impairment (MCI) has become one of the most frequently used in the past decade (Petersen et 
al., 1999). Originally, the concept was defined by subjective memory complaints (SMC), 
isolated memory impairment, otherwise normal cognitive function, intact activities of daily 
living, and the absence of a dementia (Petersen et al., 1999). In their study, the authors found 
that individuals classified as MCI demonstrated a significant higher annual conversion rate to 
AD (12%) compared to a control group (1-2%), leading to the suggestion that MCI is a 
significant risk factor for AD. 
The implementation of the original criteria has varied across studies, resulting in large 
inconsistencies with regard to prevalence rates, rates of conversion from MCI to AD, and 
stability of the diagnosis over time (Tuokko & McDowell, 2006). Likewise, it has been 
reported that a substantial number of elderly individuals in addition to a predominant memory 
impairment, or even in the lack of such an impairment, show subtle cognitive impairment in 
other cognitive domains, e.g. language, executive functions, and attention (Larrieu et al., 
2002; Lopez et al., 2003; Ritchie, Artero, & Touchon, 2001). Other studies revealed that MCI 
could be confused with depression based on similar neuropsychological profiles (Chen, 
Ganguli, Mulsant, & DeKosky, 1999; Yaffe et al., 1999). Thus, the term MCI refers to a 
condition of heterogeneous clinical presentation, etiology, and outcome. 
Recently, the original criteria were modified (Petersen, 2004), introducing a broader 
classification system which includes distinguished clinical subtypes of MCI and suggestions 
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about underlying distinct etiologies (Figure 3). The original concept, renamed amnestic MCI 
(aMCI), is thought to represent the majority of individuals who will progress to a diagnosis of 
AD over time. It is also recognized that these kind of symptoms may be related to a 
psychiatric diagnosis of depression. The other non amnestic categories include single and 
multiple cognitive domains which are considered to represent the transitional phase between 
normal aging and other forms of dementias (e.g. frontotemporal dementia (FTD), vascular 
dementia (VaD), Lewy body dementia (LBD)). The robustness of these clinically 
recognizable subtypes and the etiological linkages remain to be shown, in particular with 
regard to findings indicating no direct association between MCI subtypes and ultimate 
dementia diagnosis (Fischer et al., 2007). Moreover, the implementation and 
operationalization of the individual criteria leading to any kind of MCI classification still 
remain open, and the ongoing debate about the clinical significance and outcome of MCI will 
surely continue (Ames, Petersen, Knopman, & Gauthier, 2006). 
 
Mild Cognitive Impairment
Cognitive complaint
Not normal for age / not demented / cognitive decline /
essentially normal functional activities
MCI
Memory impaired ?
Amnestic MCI Non-amnestic MCI
Memory
impairment only ?
Single non-memory
cognitive domain
impaired ?
Amnestic MCI
Single domain
Amnestic MCI
Multiple domains
Non-amnestic MCI
Single domain
Non-amnestic MCI
Multiple domain
Yes No
Yes No Yes No
deg: AD deg: AD deg: FTD deg: LBD
psych: Depr vasc: VaD vasc: VaD
psych: Depr
Assumed etiology
 
Figure 3: The figure, adapted from Petersen (2004), shows the classification process of 
subtypes of mild cognitive impairment and the presumed underlying etiologies (bottom rows). 
(deg = degenerative; psych = psychiatric, vasc = vascular; AD = Alzheimer’s disease; Depr = 
Depression; VaD = Vascular Dementia; FTD = Frontotemporal Dementia; LBD =  Lewy 
Body Dementia) 
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Defining cognitive impairment 
Despite the convincing findings of early indicators for pathologic cognitive decline, 
the definition of “objective impairment” remains a matter of discussion. 
When Petersen et al. (1999) proposed the concept of MCI, they defined impairment as 
performance scores ≥ 1.5 standard deviations (SDs) below age-matched normative material 
on the assessed memory test. Nevertheless, the literature reveals the use of various cutoff 
scores to define impairment, ranging from 1 SD (e.g. Busse, Hensel, Guhne, Angermeyer, & 
Riedel-Heller, 2006; Crowell, Luis, Vanderploeg, Schinka, & Mellan, 2002; Palmer, 
Bäckman, Small, & Fratiglioni, 2006) to 1.96 SD (Bickel, Mösch, Seigerschmidt, Siemen, & 
Förstl, 2006), and varying cutoffs have been used for different MCI subtypes (Zanetti et al., 
2006). One rational behind the choice of low cutoffs is that an overly stringent cutoff score 
might limit the likelihood of detecting early stages of impairment (Crowell et al., 2002). On 
the other hand, a lower cutoff may result in a higher rate of individuals falsely identified as 
impaired. Busse et al. (2006) examined the consequences of varying cutoffs and concluded 
that a lower cutoff (1 SD below the mean of age- and education-specific norms) should be 
applied when high sensitivity is requested, while a more stringent cutoff (1.5 SD below the 
mean of age- and education-specific norms) should be applied when high specificity and high 
positive predictive power is required. 
The use of cutoff scores has been disputed repeatedly and it has been pointed out that 
psychometric cutoff scores should not be crucial for the classification as MCI, but that the 
classification should be based on clinical judgment based on an overall impression from 
several assessment sources (Petersen, 2004; Winblad et al., 2004). However, some authors 
have expressed concern about this suggestion, as they see a risk that this might prevent the 
work to specify precise criteria (Tuokko & McDowell, 2006). They argue that clinical 
judgment comprises multiple factors, e.g. patient and rater characteristics as well as 
measurement issues which individually may influence the reliability of the evaluation of 
cognitive impairment. 
In addition to the arbitrary use of cutoff scores, there is a considerable number of 
factors which may influence performance results and in turn a definition of impairment. This 
includes factors inherent to the measures themselves (e.g. reliability, validity, test demands), 
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the assessment environment (e.g. participants anxiety, fatigue), and the frequency of 
assessment procedures. 
 
Olfaction 
The human sense of smell has often been described as poor and inferior in comparison 
to the other senses (Köster, 2002). However, besides its well known importance for survival 
and reproduction (Doty, 2003), an increasing body of research has contributed to the 
understanding by identifying the neuronal bases and the organization of olfaction (Savic, 
Gulyas, Larsson, & Rolland, 2000; Zelano & Sobel, 2005;), its relevance for quality of life 
(Blomqvist, Brämerson, Strjärne, & Nordin, 2004; Hummel & Nordin, 2005) as well as its 
clinical importance (Holbrook & Leopold, 2006). 
 
Olfactory changes in aging 
Impaired olfactory functioning (hyposmia) appears in about 20% of the general 
population, whereas a lack of smell functioning (anosmia) is estimated to be present in about 
5% of the population (Brämerson, Johansson, Ek, Nordin, & Bende, 2004; Landis, Konnerth, 
& Hummel, 2004; Murphy et al., 2002). These numbers increase significantly with age and 
beyond the age of 70 years more than 50% of all individuals may be affected (Doty et al., 
1984; Murphy et al., 2002). Thus, a significant number of elderly individuals will experience 
age-related olfactory dysfunction that may impair health and well-being, self-sufficiency, and 
quality of life (Hummel & Nordin, 2005). But despite the far-reaching consequences, 
olfactory dysfunction often remains unrecognized, and few elderly individuals report 
impairment to their physicians either because they fail to notice the gradual decline or they 
attribute it to normal changes associated with aging (Murphy et al., 2002; Nordin, Monsch, & 
Murphy, 1995).  
A decline in olfactory function most commonly starts in the 5th and 6th decade of life 
with a considerable drop in the 7th decade (Doty et al., 1984; Brämerson et al., 2004). The 
age-related impairment of olfactory functioning can be observed across several olfactory 
domains, including basal functions such as detection sensitivity (the ability to detect the 
presence of an odor) (Stevens & Cain, 1987) and discrimination (the evaluation whether the 
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presented odors are identical or differ from each other) (Schiffman & Pasternak, 1979), and in 
tasks involving cognitive processes such as odor identification (the ability to identify and find 
the appropriate verbal label for an odor) (Doty et al., 1984; Larsson, Nilsson, Olofsson, & 
Nordin, 2004), and odor recognition (Larsson & Bäckman, 1997). 
Besides age, gender differences in olfactory functioning suggesting a female 
advantage are commonly reported (Doty et al., 1984; Brämerson et al., 2004; Murphy et al., 
2002). While studies have not consistently found a better female performance on sensitivity 
tests (Öberg et al., 2002), results are more consistent for olfactory tasks requiring cognitive 
processing such as odor identification tests. Using an odor identification task in a community-
based study, Doty et al. (1984) found higher performance scores in women than men at all 
ages. In a population-based study including participants above the age of 50 years, Murphy 
and colleagues (2002) found a higher prevalence of olfactory dysfunction in men (aged 50-97 
years) and an interaction effect between gender and age. However, an interaction effect was 
not corroborated by results from two separate population-based studies (Brämerson et al., 
2004; Larsson et al., 2004). The reasons for a female advantage remain still not well 
understood. Based on results from studies assessing odor memory, some authors have 
suggested that a female advantage in verbal processing may contribute to the differences 
(Öberg, Larsson, & Bäckman, 2002). 
The olfactory dysfunction associated with increasing age may be caused by several 
factors, including age-related histological changes (e.g. neurogenesis of olfactory cells), 
somatic or health-related variables (e.g. trauma, diabetes, surgery, medication), environmental 
factors (e.g. exposure to toxins) (for an overview see for example Seiberling & Conley, 2004), 
and cognitive functioning (Larsson, Finkel, & Pedersen, 2000; Larsson et al., 2004; Larsson, 
Öberg, & Bäckman, 2005). 
 
Odor identification 
Odor identification refers to the ability to retrieve the correct name of an odor. This 
process requires that the individual has formerly experienced an odor and that an odor-name 
association has been established. Thus, odor identification relies on semantic memory 
function, the system where an individual’s knowledge is stored (Gazzaniga, Ivry, & Mangun, 
2002). In practice, the identification of odors without cues has shown to be difficult, and 
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performance on odor identification tasks has hardly shown to exceed 50% (Engen, 1987). 
Several suggestions have been made to explain the poor performance. Based on experiments 
demonstrating that initial free identification performance improved significantly over trials 
when feedback was provided and that label quality improved over consecutive trials (e.g. 
from far miss to veridical), Cain (1979) suggested that poor identification performance could 
be referred  to a poor linkage/association between odors and names, a failure to retrieve the 
odor-name association (implicating that knowledge is existent but that it needs support to be 
utilized), or a failure in perception, that is a misperception leading to difficulties in 
identification. Based on findings showing that individuals had more difficulties to generate 
information about an odor’s name than to describe the qualitative feature of an odor, Engen 
(1987) suggested that an inherently weak association between odors and names is responsible 
for poor identification. Other authors have suggested that a lack of formalized learning 
procedures may account for naming difficulties (de Wijk, Schab, & Cain, 1995). They argue 
that odors are learned gradually and in reference to the objects that release them or to a 
specific context. Thus, smell perceptions may be interpreted and stored in accordance to the 
available information. Besides the verbal-semantic factors it has been suggested that 
impairment in sensory-perceptual functioning may lead to failures in odor identification 
(Cain, 1979). Obviously, a certain degree of sensitivity is required to be able to discriminate 
and identify odors. However, findings indicate that deficits seen in odor identification 
performance in older individuals cannot exclusively be related to sensory deficits but seem to 
be related to cognitive limitations (Larsson & Bäckman, 1997; Murphy, Cain, Gilmore, & 
Skinner, 1991).  
The relationship between odor identification performance and cognitive functions is 
not well characterized. It has been shown that performance is dependent on the cognitive 
demands of the odor identification task: the availability of response alternatives increases 
identification performance significantly (Doty et al., 1984). Thus, by bypassing the 
difficulties of name generation/retrieval of a name from semantic memory the cognitive 
demands will decrease. However, performance has not shown to be perfect despite of 
available cues. Another factor influencing performance has shown to be the distinctiveness of 
response alternatives. Engen (1987) found that performance increased significantly (on 
average 93% correct) when response alternatives were highly distinctive compared to 
approximately 50% correct answers when response alternatives were similar to the target that 
had to be identified. Studies investigating the associations between cognitive measures and 
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cued odor identification performance have demonstrated that general semantic knowledge 
(Larsson et al., 2000, 2004), processing speed (Larsson et al., 2004), and episodic memory 
(Economou, 2003) were positively related to successful odor identification performance. A 
study examining the association between free odor identification and cognitive measures 
revealed significant correlations between olfactory performance and measures of processing 
speed and verbal fluency (Larsson et al., 2005). 
A factor that has attracted little attention in relation to odor identification performance 
is education. In that the number of years spent in the educational system may correlate with 
cognitive abilities, it may influence odor identification performance through the influence on 
semantic memory function. Studies so far have been inconsistent with regard to the influence 
of education. Larsson et al. (2004) and Olofsson et al. (in press) found that education was 
positively correlated with odor identification performance, but this influence was not reliably 
confirmed in other studies (Larsson et al., 2000, 2005).  
 
Despite the difficulties of verbal identification, the sensation of an odor often elicits a 
feeling of familiarity. Cain (1980) used the term “preverbal identification” referring to the 
condition where the generation of a verbal label is impossible although the individual is able 
to indicate that an odor is familiar. Lawless and Engen (1977) introduced the “tip of the nose”  
phenomenon where the individual experiences a strong feeling of familiarity, possibly able to 
specify an odor’s source and access information about its quality, but not to retrieve the name. 
Köster (2002) pointed out that the feeling of familiarity may be of greater importance in real 
life when an odor is detected or recognized in order to behave adequately. According to 
Larsson (2002), different degrees of familiarity may be distinguishable, indicating the 
“implicit level of odor knowledge” (Larsson, 2002, p.236). Thus, low familiarity may be 
generated by a vague perception that cannot be associated with semantic information, while a 
high degree of familiarity may reflect access to more detailed information or possibly even 
access to a name. Schab (1991) proposed that knowledge on the complex process of odor 
identification could be increased if response accuracy admitted more than a single verbal 
label. He suggested to conceptualize odor identification as continuum with different levels of 
informational specificity: reaching from a basic feeling of familiarity, through a level of wide 
ranging identification including broad descriptions and some kind of specific knowledge, to a 
final level of identification where the individual is able to identify an odorant by a specific 
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name. So far, few studies have investigated the interrelation of different levels of odor 
identification and their association with cognitive functions. Cain (1979) reported that 
familiarity has an impact on identification: when responses were divided in categories labeled 
as “veridical”, “near miss”, and “far miss”, he found that odors evaluated as highly familiar 
often received a verdical label. However, results also demonstrated that odors rated as highly 
familiar could receive labels belonging to the category “far miss”. Other studies indicate that 
high familiarity increases odor recognition performance (Larsson & Bäckman, 1997; Rabin & 
Cain, 1984). 
 
Tests of odor identification 
Different tests of odor identification have been developed for different cultural regions 
and clinical settings, e.g. the University of Pennsylvania Smell Identification Test (UPSIT; 
Doty, Shaman & Dann, 1984) and the Connecticut Chemosensory Clinical Research Center 
Identification Test (Cain, 1989) have been developed in the USA, and the Sniffin' Sticks in 
Central Europe (Kobal et al., 1996). The reason for having developed several tests of this kind 
is due to cultural aspects of the test odors. Thus, correct identification is possible only if the 
individual has had previous experience with the odor quality. The Scandinavian Odor 
Identification Test (SOIT, Nordin et al., 1998) was developed in Sweden to provide a test 
valid for the Scandinavian population. It contains 16 odorous items as natural oils that are 
kept in glass bottles. So far, its applicability has also been demonstrated for Finish 
populations (Nordin, Nygroos, Maunuksela, Niskanen, & Tuorila, 2002). 
 
Olfactory dysfunction in Alzheimer’s disease and individuals at risk for Alzheimer’s 
disease 
A large body of evidence has demonstrated olfactory impairment in AD (Kovács, 
2004; Mesholam, Moberg, Mahr, & Doty, 1998; Murphy, 1999). Results from earlier studies 
demonstrated significant correlations between odor identification scores and the Mini Mental 
State Examination (MMSE; Folstein, Folstein, & McHugh, 1975), supporting the usefulness 
of olfactory tasks in detecting olfactory dysfunction occurring together with the cognitive 
deficits in AD (Koss, Weiffenbach, Haxby, & Friedland, 1988; Serby, Larson, & Kalkstein, 
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1991). Studies using olfactory threshold tests have been less consistent in showing 
impairment in AD. While some authors have reported impairment (Knupfer & Spiegel, 1986), 
others have not (Koss, Weiffenbach, Haxby, & Friedland, 1987). Furthermore, odor detection 
levels have not always shown significant correlations with performance score on the MMSE 
(Larsson et al., 1999; but see also Murphy, Gilmore, Seery, Salmon, & Lasker, 1990), and 
impaired odor identification performance has been found despite normal detection levels 
(Koss et al., 1988; Serby et al., 1991). Morgan, Nordin, and Murphy (1995) suggested that 
detection impairment in AD may contribute to the observed deficit in identification 
performance, although additional cognitive components seem to contribute to the impairment. 
In a meta-analysis, Mesholam et al. (1998) concluded that odor detection, discrimination and 
identification were likely to be equally impaired in AD, and that divergent results concerning 
threshold tests could be due to assessment difficulties. 
The apparent olfactory deficits seen in AD are suggested to correspond to the 
pathological changes in AD taking place in temporal lobe structures. Early pathological 
changes have been demonstrated in the entorhinal cortex (Braak & Braak, 1991), an area of 
high importance in olfactory processing: it receives input from the olfactory bulb through the 
lateral olfactory tract, the frontal cortex and the amygdala and projects to the hippocampus 
and orbitofrontal cortex (Cleland and Linster, 2003; Savic et al., 2000; Sobel, Johnson, 
Mainland, & Yousem, 2003). Other studies have reported that earliest pathological changes in 
AD involve the olfactory bulb (Hyman, Arrigada, & Van Hoesen, 1991; Kovács, Clairns, & 
Lantos, 2001). Thus, areas that are important for the processing of olfactory information are 
among the first affected by neuropathological changes in AD. 
The findings of olfactory deficits in AD has motivated researchers to investigate 
olfactory functioning in individuals at risk of AD, e.g. individuals carrying the ε4 allele and 
individuals classified as MCI. Bacon, Bondi, Salmon, and Murphy (1998) found higher 
threshold levels in ε4 carriers the year prior to an AD diagnosis compared to the threshold in 
those individuals who did not progress to AD. Other studies have demonstrated lower odor 
identification performance scores in ε4 carriers compared to scores in a control group 
(Murphy, Bacon, Bondi, & Salmon, 1998; Suzuki et al., 2004; Wang et al., 2002). A more 
recent study failed to replicate those findings (Handley, Morrison, Miles, & Bayer, 2006). 
However, results revealed the greatest impairment in odor identification in ε4 carriers with a 
positive family history compared to non carriers with a positive family history of AD and ε4 
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carries in the control group. The authors concluded that odor identification deficits may not 
solely be caused by the possession of the ε4 allele. Two longitudinal studies reported 
significant differences in odor identification performance between ε4 carriers and non carriers 
(Calhoun-Haney & Murphy, 2005; Olofsson et al. in press). Calhoun-Haney and Murphy 
(2005) found that elderly ε4 carriers showed a larger decline in odor identification 
performance than non carriers. Olofsson et al. (in press) reported a significant difference in 
odor identification performance between ε4 carriers and non carriers in a group of 75-80 year 
olds. In the latter study, both genotype groups demonstrated decline in global cognitive 
functioning (MMSE) and odor identification performance, and the ε4 allele was shown to be 
associated with progression to dementia. However, a significant effect of genotype remained 
when preclinical and diagnostic cases of dementia were controlled for. 
Studies investigating patients classified as MCI indicate that these patients may 
perform lower on odor identification tasks than normal individuals (Devanand et al., 2000; 
Djordjevic, Jones-Gotman, DeSousa, & Chetkow, 2008; Westervelt, Bruce, Coon, & 
Tremont, 2008). Westervelt et al. (2008) found that odor identification performance was 
impaired in MCI patients compared to normal controls but better than in patients with AD. 
Notably, the results did not show significant differences in clinical subtypes of MCI. 
In a longitudinal study examining MCI patients, Devanand et al. (2000) reported that 
olfactory impairment was predictive for progression to AD. In addition, the authors pointed 
out that unawareness of olfactory dysfunction could be of particular interest. Their analyses 
revealed that low olfactory performance did not predict time to develop AD when 
demographic and clinical variables were controlled for. However, it was possible to predict 
time to development of AD when the status of unawareness of olfactory deficit in addition to 
impaired olfactory performance was included in the analyses. Thus, the authors suggested a 
unique contribution of the status of unawareness to the prediction of time to develop AD. 
It has also been debated whether olfactory impairment in non demented elderly may 
be associated with decline in general cognitive ability (Graves et al., 1999; Swan & Carmelli, 
2002). Longitudinal studies in healthy elderly individuals have demonstrated that cognitive 
decline, predominantly in episodic memory functioning and perceptual speed, can be 
predicted by performance on odor identification tasks (Swan & Carmelli, 2002; Wilson, 
Arnold, Tang & Bennett, 2006). It is, however, important to note that these studies differ in 
their strictness of excluding individuals with cognitive impairment at follow up examination, 
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and thus eventually might have included individuals in an early phase of AD. Another study 
reported an accumulation of amyloid plaques and neurofibrillary tangles in the entorhinal 
cortex and hippocampus of community-dwelling elderly individuals accounting for 12% of 
the variance in an odor identification task that had been administered on average 2.2 years 
before death (Wilson, Arnold, Schneider, Tang & Bennett, 2007). The authors reported 
further, that controlling for AD did not mediate the relationship between odor identification 
performance and neuropathology in the olfactory processing areas. This could imply that 
neuropathological changes that impair olfactory functioning are also present in individuals 
free from dementia. 
In sum, findings demonstrate that olfactory impairment, particular in odor 
identification performance may occur at a very early stage of AD, prior to the onset of typical 
cognitive and behavioural disturbances. This prompted the suggestion that olfactory 
assessment could be a useful adjunct in the neuropsychological assessment to detect early AD 
(Graves et al., 1999; Morgan et al., 1995).  
 
SUMMARY OF STUDIES 
Research questions 
This thesis has focused on the age period in life where cognitive and sensory changes often 
commence and consecutively may become more distinct. A series of cross-sectional was 
carried out to investigate the following issues:  
1) The research aim in paper 1 was to investigate patterns of cognitive performance in a 
Norwegian sample of ApoE ε4 carriers and to evaluate if these were similar to those 
shown in earlier samples from other populations, e.g. Bondi et al., (1995; 1999). This 
question was motivated by findings indicating differences between varying ethnic 
groups with regard to an ApoE ε4 - AD association and by the finding showing that 
individuals from Nordic countries more frequently are carriers of the ε4 allele. 
2) Paper 2 addressed the question whether the SOIT and its cut-off scores for diagnosis is 
applicable and valid to be used in Norwegian samples (middle aged and older 
individuals). Would results reveal performance differences between Norwegian and 
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Swedish individuals and would frequencies of diagnosis of olfactory dysfunction 
differ? 
3) Two research questions motivated paper 3. The first referred to whether the number of 
individuals unaware of their olfactory deficit would increase significantly with age. 
The second question referred to whether cognitive function in individuals unaware of 
their olfactory dysfunction, and to whether this group showed different performance 
on cognitive tasks compared to individuals who showed normal olfactory functioning. 
4) Paper 4 addressed the question how different components of the odor identification 
process (i.e. tasks assessing familiarity, cued and free identification) interrelate, how 
they relate to various cognitive measures and whether age-related performance 
differences could be found in the three olfactory tasks. 
 
METHODS 
Participants  
The samples included in the studies presented were recruited from two different 
projects on cognitive aging. The first study included a sample of 70 individuals aged 50-75 
years who were referred to clinical assessment in a research project through their primary 
physician. These individuals sought help for memory deficits and subjective memory 
complaints that had lasted for at least 6 month which was an inclusion criterion in addition to 
an estimated IQ score > 80 and an MMSE score ≥24. Participants had to be free from 
dementia based on results from the study protocol. 
The remaining three studies in this thesis included community-dwelling samples of 
middle aged and older individuals (45-80 years), recruited through advertisement in local 
newspapers in Bergen and Oslo. For the detailed exclusion criteria, see individual papers. The 
varying sample sizes in the different papers relate to either specific exclusion criteria and/or 
the availability of data. 
 
Neuropsychological assessment   
In the present thesis, the following neuropsychological tests assigned to cognitive domains 
have been used:  
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General intellectual abilities were assessed using the Norwegian translation (Ørbeck, 
& Sundet, 2007) of subtests from the Wechsler’s Abbreviated Scales of Intelligence (WASI; 
Wechsler, 1999). The subtest Matrices was used to assess nonverbal fluid reasoning and the 
Vocabulary subtest yields a measure of general verbal ability. Based on these two subtests, a 
total IQ score was estimated according to the available norms. To obtain measures of memory 
function, the California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 2000; 
Norwegian translation: Sundet & Lundervold, 2004), the Rey-Osterrieth Complex Figure Test 
(Osterrieth, 1944; translation: Corwin & Bylsma, 1993), and the Verbal Paired Associates 
Test (Andersen, 1976) were included. Different aspects of executive functioning were 
assessed using the Trail Making Test B (Reitan & Davidson, 1974) and the Color-Word 
Interference Test (Delis, Kaplan, & Kramer, 2001)/Stroop Color Word Test (Jensen & 
Rohwer, 1966). The Controlled Word Association Test (COWAT; Benton & Hamsher, 1989) 
and the Boston Naming Test (BNT; Kaplan, Goodglass, & Weintraub, 1983) were used to 
obtain measures of verbal function. The Digit Symbol Test (Wechsler, 1981) and the Trail 
Making Test A (Reitan & Davidson, 1974) yielded measures of attention and psychomotor 
speed. In paper 3, the revised version of the Everyday Memory Questionnaire (EMQ; 
Baddeley, 1997; Sunderland, Harris, & Gleave, 1984) was included to asses subjective 
evaluation of memory functioning. 
 
Olfactory assessment 
Olfactory assessment included a questionnaire on self-reported factors potentially 
influencing olfactory functioning (adapted from the Multi-Clinic Smell and Taste 
Questionnaire; Nordin, Brämerson, Murphy, & Bende (2003)) and questions about the self-
reported status of the sense of smell. Time restrictions implicated that detection sensitivity 
was assessed by using a simplified version of the CCCRC Threshold Test (Cain, 1989) to 
describe the participants in terms of normosmia, hyposmia or anosmia with respect to 
detection sensitivity. Detection of 55 ppm butanol was categorized as normosmia, detection of 
4444 ppm but not 55 ppm as hyposmia, and no detection of 4444 ppm as anosmia. 
Scores on the ability to identify odors were obtained by using the SOIT (Nordin et al., 1998). 
In addition to the standard procedure, participants were asked to make judgments of 
familiarity on individual items and freely identify a presented odor before cues for 
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identification were provided. Since the odor identification task will continuously be used, a 
disclosure of the response alternatives here is not possible.    
 
SUMMARY OF RESULTS  
Paper 1: ApoE status and its association to learning and memory performance in middle aged 
and older Norwegians seeking assessment for memory deficits 
This study examined whether deficits in learning, memory and other cognitive 
functions were more prominent in carriers of the ε4 allele compared to non carriers, recruited 
from a population with a high prevalence of the ε4 allele. The sample comprised 70 
consecutively referred patients aged 50-75 seeking assessment due to subjective memory 
complaints. Participants included in the study were classified as non demented based on 
clinical evaluation and results on cognitive tests. Fifty-six percent of the individuals in the 
sample were carriers of the ε4 allele. These individuals showed poorer performance than non-
carriers on the MMSE, on a number of measures of verbal memory function from the CVLT, 
and on visual recall. In 46% of the participants, psychometric criteria for aMCI were met, 
based a performance score ≥ 1.5 SDs below the age and gender adjusted norm on the delayed 
free recall measure from the CVLT. The findings may partly be explained by a significant 
number of participants being in a preclinical phase of AD. However, the observed deficits in 
learning performance and the lack of significant age modulation of the genetic association 
suggest a more general genetic effect. The findings are consistent with known neurobiological 
function of ApoE ε4, including both increased risk of neurodegenerative disease and reduced 
synaptic integrity in older age.  
 
Paper 2: Applicability of the Scandinavian Odor Identification Test for Norwegian use and 
age-related effects 
The objective of this study was to evaluate the applicability of the SOIT for 
Norwegian use since it was developed and validated on Swedish participants. Other 
objectives were to study at what age performance in odor identification most clearly declines 
and whether diagnosis of olfactory dysfunction was comparable in Norwegian and Swedish 
samples. SOIT results of 256 Norwegian participants were compared with the results of 667 
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Swedish participants. The participants were divided into three age groups: 45-54 (young 
middle-aged), 55-64 (old middle-aged) and 65-75 (old) years. Results revealed that the 
Norwegian participants did not differ from the Swedes in their performance on the SOIT or in 
diagnostic distribution based on cut-off scores of the test. Gender- and age-related effects on 
identification performance in the Norwegians imply prognostic validity of the SOIT. The age-
related effect-size was larger when comparing old middle-aged with the old, than when 
comparing the young middle-aged with the old middle-aged. The findings suggest that the 
SOIT is valid for use in Norwegian samples, and that the ability to identify odorous items is 
fairly well preserved at middle age, declining predominantly at old age. 
 
Paper 3: Unawareness of olfactory dysfunction and its association with cognitive functioning 
in middle aged and older adults 
One aim of this study was to investigate the accordance of subjectively (self-reported) 
and objectively (test of odor identification) assessed olfactory functioning. A second aim was 
to compare those individuals unaware of their olfactory dysfunction with those with normal 
olfactory function with respect to performance on cognitive tests. In total 253 participants, 
constituting a group of middle aged and a group of old, were evaluated with the SOIT, a 
question of self-evaluated olfactory function, neuropsychological tests of cognitive function, 
and the EMQ. Among those with an olfactory dysfunction, the proportion being unaware of 
the olfactory dysfunction was high in both middle aged (83%) and old (70%) participants. 
Performance on neuropsychological tests showed that persons unaware of their olfactory 
dysfunction performed poorer on cognitive tests of verbal learning and memory function, 
attention and executive functioning than participants with normal olfactory function. In the 
middle aged group, the results also revealed that the participants unaware of their olfactory 
dysfunction reported more memory difficulties. Our findings strongly suggest that self-reports 
and objective assessment of olfactory function has clinical relevance in the evaluation of 
aging individuals. 
 
Paper 4: Familiarity, cued and free odor identification and their association with cognitive 
functioning in middle aged and older adults 
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The aim of the study was to examine the association between familiarity, cued and 
free odor identification performance and cognitive and demographic variables in healthy 
middle aged and older adults. It was hypothesized that the three olfactory tasks would be 
associated with different measures of cognitive functioning and that age would affect 
performance differently. Based on the argument that a decline will be most apparent on tasks 
demanding effortful processing, we expected that the age-related decline would be most 
pronounced in the free identification task. A third aim was to investigate the role of 
familiarity in explaining performance on free identification. One-hundred and thirty six 
participants (aged 45-79 years) with normal olfactory sensitivity were assessed with the SOIT 
and standardized tests of cognitive function. Results revealed that familiarity ratings did not 
correlate with any of the cognitive measures, while cued odor identification was related to a 
larger number and free odor identification with the largest number of cognitive variables. For 
both identification tasks, the strongest correlations were found for scores on processing speed 
and verbal memory. In this sample, only free odor identification showed a marginal 
significant decline with age. The results suggest that the different olfactory tasks involve 
different levels of cognitive processing. 
 
DISCUSSION  
The papers included in the thesis addressed questions related to cognitive and 
olfactory changes in elderly individuals with an aim to gain knowledge on the influence of the 
ApoE ε4 genotype on cognition and to extend the understanding of the association between 
cognitive functioning and odor identification performance. The first paper demonstrated that 
the ApoE ε4 genotype is associated with poorer cognitive performance on measures of verbal 
learning and memory function in a sample recruited from a population with a high frequency 
of the ε4 allele. In a series of studies on olfactory functioning, the applicability of the SOIT in 
a Norwegian sample was shown and it was demonstrated that olfactory dysfunction is present 
in a considerable number of elderly individuals. The findings suggest further that 
unawareness of olfactory dysfunction is associated with lower performance on measures of 
verbal learning and memory function in elderly individuals and that the process of odor 
identification is correlated with different measures of cognitive functioning. 
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ApoE ε4 and cognitive performance  
The first paper contributes to the debate on whether the ApoE ε4 allele affects 
cognitive performance, in particular episodic memory function, in non demented individuals. 
Earlier findings were replicated in a sample recruited from a population with a high frequency 
of the ε4 allele. Thus, our findings are congruent with other studies discussed in the 
introduction (e.g. Bondi et al., 1995; 1999) and strengthen the generality of previous findings. 
The possibility that individuals in a preclinical stage of AD were included in the sample was 
discussed. The findings stress the importance of longitudinal studies investigating genetic 
influences in different populations with different frequencies of a specific genotype. In a 
study from the Betula project, a population-based longitudinal study in Sweden, where also 
elevated frequencies of the ApoE ε4 allele have been reported (Eggertsen, Tegelman, 
Ericsson, Angelin, & Berglund, 1993), Nilsson et al. (2006) observed ε4-related deficits in 
particular for recall measures of episodic memory. The authors explicitly discussed the risk of 
the inclusion of preclinical cases of AD and excluded individuals who had developed AD 
within the final testing point. They concluded that despite the possibility of further preclinical 
cases of AD in their sample, the dose effect shown in their data supported a differential effect 
of the ApoE ε4. 
An explanation for the south-to-north gradient remains unknown. Gerdes (2003) 
speculated that ApoE ε4 may be an important factor for survival as it may protect against 
vitamin D deficiency which occurs in areas with periods of shortened/no sunlight. He further 
suggests that ApoE ε4 may either be related to a better re-absorption of the vitamin or 
increase its production. This remains a topic of further research. 
The ApoE gene is regarded as one of the most important genes influencing cognitive 
aging and risk for AD. Although several other genes have been suggested to be related to AD, 
these associations seem weak and not always replicable (Bertram & Tanzi, 2004). In studies 
focusing on non pathological changes in aging other genetic factors have been shown to exert 
influences on cognition. For example, de Frias et al. (2004; 2005) found that polymorphisms 
of the catechol O-methyltransferases (COMT) gene are related to decline in executive 
functioning in elderly adults. Furthermore, Espeseth et al. (2006) showed that interactive 
effects of genes (ApoE and a nicotinic receptor subunit gene (CHRNA4)) may be responsible 
for differences in behavioral data. In a review concerning genetic influences on normal 
cognitive aging, Deary et al. (2004) concluded that the impact of genes on cognition emerges 
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from a life-long general factor and age-specific factors. The authors suggested, that the effects 
of individual genes seem to be rather small and that cognitive functions are likely to be 
influenced by a combination of effects from several genes (polygenic effects). They argued 
that also genetic influences seen in normal aging may be due to an accumulation of several 
late-onset disease-related polygenic effects which indirectly might exert an influence on 
cognition.  
 
Mild cognitive impairment in patients seeking help for memory impairment 
Besides the findings concerning ApoE and cognitive performance, the first paper 
highlights some of the challenges associated with the concept of MCI, and two aspects should 
be addressed here. Our definition of aMCI was based on criteria proposed by Petersen et al. 
(1999) and required an objective cognitive impairment (≥ 1.5 SDs below peer norms) on one 
particular measure (delayed free recall from the CVLT) at a single point of time. In the 
context of our study this definition seemed reasonable as measures of episodic memory 
function have shown to be particularly sensitive to effects of the ε4 allele and to be good 
predictors of decline to AD. Thus, our objective was primarily to examine how many 
individuals defined as aMCI were carriers of the ε4 allele. However, with regard to the 
initially cited literature it seems reasonable to discuss whether the combination of cognitive 
measures would have added important information. It would be of interest to examine how 
many of the individuals classified as aMCI were impaired on tests of other cognitive domains 
e.g. executive functioning. These kinds of analyses could contribute to the discussion on 
subtypes of MCI and on the utilization and availability of compensatory resources. Thus, the 
combination of measures seems indicated to improve the knowledge about patterns of 
cognitive changes. Furthermore, the finding that 45% of the sample was classified as aMCI 
whereas a large proportion remained “unlabled” or considered “unimpaired” seems to deserve 
some comment. Having in mind that the participants in the study were recruited in a clinical 
setting, a higher occurrence of individuals with cognitive impairment was expected. A 
different definition of impairment (e.g. 1 SD below norms on the same measure) would have 
classified 63% as aMCI, while only 30% would have been in that group if we had chosen to 
base our definition on results (1.5 SDs below norms) from the Verbal Paired Associates Test. 
Furthermore, it is not possible to exclude the fact that the individuals performing in a 
“normal” range did not actually experience a decline: they might have had a high former level 
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of cognitive functioning, making them aware and worried about an age-related decline. In 
sum, this demonstrates that varying cutoffs and tests engender different groups of individuals 
and yield different types of information. Accordingly, rates of conversion from MCI to 
dementia may vary substantially. This highlights some of the concerns associated with the 
concept of MCI. The question is whether we should, based on the above discussed findings, 
label an individual with a term that means that someone does not have AD, or has it, or might 
get it. One suggestion could be to omit assumptions about the underlying pathological causes 
but rather use MCI descriptively (Tuokko & Hultsch, 2006). This may be enough to make 
MCI useful in a clinical setting where the clinician recognizes that a patient has cognitive 
deficits and decides to follow him/her up carefully, refer him/her to special 
assessment/examination, and suggest community support to maintain quality of life. 
 
Applicability of the SOIT 
The second paper established a basis for the application of the SOIT. Despite an 
eventual intuitive assumption that there are few cultural differences between Norwegian and 
Swedish individuals, we found it reasonable to investigate the applicability of the SOIT in 
Norwegian participants before using it on extended research questions. Our results introduce 
and qualify the SOIT as a standardized method to assess odor identification performance in 
Norwegian samples. One general concern with regard to our study may be the format of its 
presentation. We used the standardized version of the SOIT, including response alternatives 
that may be considered rather distinct, based on the argumentation that its applicability had to 
be confirmed to be able to further use this version in clinical as well as in research settings. 
Our results revealed a distribution that was slightly negatively skewed, so that caution seems 
appropriate when using the SOIT in well functioning samples of adults. However, since no 
differences were found between Norwegian and Swedish data, the latter collected from a 
population-based study; this seems sufficient evidence for our conclusions. The results enable 
further studies in clinical samples with regard to sensitivity and specificity. Other studies have 
demonstrated that specific item analyses could be of further interest: Ashendorff, 
Constantinou, Duff, and McCaffrey (2005) analyzed the individual items of the UPSIT (Doty 
et al., 1984) in community dwelling adults. Based on the results revealing that a number of 
items were generally poorly identified by elderly individuals, the authors suggested that 
deficits in the remaining items (which were not generally poorly identified) could signal 
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atypical olfactory deficits which could be of interest for clinicians. Another study revealed 
that item-specific pleasantness influenced overall identification performance, i.e. unpleasant 
odors were more consistently identified while identification of pleasant odors showed more 
age-related variance (Konstantinidis, Hummel, & Larsson, 2006). In sum, item analyses may 
further increase knowledge on the age-related changes seen in odor identification 
performance. 
 
Unawareness of olfactory dysfunction  
Paper 3 investigated age-related changes in unawareness of olfactory dysfunction 
based on performance on the SOIT. On the one hand, these findings have practical relevance 
as unawareness may be linked to risks in everyday life, such as detection of smoke, gas leaks, 
or spoiled food. Thus, persons working with elderly individuals should be made aware of the 
risk of olfactory deficits and possible implications. On the other hand, the results animate a 
number of questions by showing an association between the status of unawareness and 
diminished cognitive performance. Also earlier studies have reported an age-related increase 
in unawareness of olfactory dysfunction (Murphy et al., 2002; Nordin et al., 1995), although 
few have investigated further implications. Devanand et al. (2000) suggested that 
unawareness of olfactory dysfunction in MCI patients could possibly serve uniquely in the 
prediction of time to develop AD. Our results do not allow such far reaching suggestions but 
may be considered as a starting point for further questions and research. The request to 
estimate ones own sense of smell requires the individuals’ access to information of his/her 
current olfactory status. This process of determining one’s own abilities and disabilities is a 
part of meta-cognition, the part of mental function responsible for monitoring and regulating 
behavior. Meta-cognition is a multidimensional construct, and research concerning meta-
cognition and age has mostly focused on memory functioning (Hertzog & Hultsch, 2000). 
One prominent example is the issue of cognitive complaints, in particular subjective memory 
complaints (SMC). So far, neither cross-sectional (Jonker, Launer, Hooijer, & Lindenboom, 
1996; Jungwirth et al., 2004; Podewils, McLay, Rebook & Lyketsos, 2003) nor longitudinal 
studies (Dufoil, Fuhrer, & Alperovitch, 2005; Martin & Zimprich, 2003; Frerichs & Tuokko, 
2006) have provided conclusive results on whether SMCs have predictive validity for 
objective memory impairment or future development of AD. However, in a review, Jonker, 
Geerlings, and Schmand (2000) concluded that individual characteristics and the context in 
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which complaints are expressed may be decisive. That is, complaints in a clinical setting 
might have a different validity than responses to a questionnaire in population-based studies. 
More recently, Fisk and Rockwood (2005) suggested that there could be a graded risk 
associated with subjective and objective impairment. That is, individuals with neither 
subjective nor objective impairment may have the lowest risk of progression to dementia, 
followed by a higher risk if objective impairment but no subjective complaint is present, and 
the highest risk where both subjective and objective impairment exist. Additionally, it has 
been shown that awareness of cognitive deficits in MCI patients may range from clear insight 
and even overestimation (Clément, Belleville, & Gauthier, 2008; Kalbe et al., 2005) to a level 
of severe unawareness comparable to the one seen in patients with AD (Vogel et al., 2004). 
These studies strengthen the view that aspects of meta-cognition may contain important 
information with regard to changes in functioning. 
Our findings raise the question why some elderly individuals fail to update their meta-
cognitive knowledge on olfactory function. At this point it has to remain speculative, but one 
hypothesis could be that some individuals receive little feedback on olfactory functioning in 
everyday life. Then, unawareness would be rather normal. However, this could also generate 
the question on how feedback on olfactory functioning is integrated in meta-cognition. Would 
individuals have given the same estimation about their function if they had been asked after 
completion of the task?  Another concern may be the way of assessment: The question in 
study 3, “How do you estimate your sense of smell?” is rather global and the individuals did 
not obtain any detailed information on the tasks besides that their smell function would be 
assessed. Nordin et al. (1995) used a similar procedure to assess odor detection sensitivity. 
Thus, the question used here may not have mapped directly into odor identification ability but 
was possibly rather associated with the ability to detect odors. It is therefore important to 
replicate the findings with specific questions regarding awareness of detection sensitivity and 
identification ability. In sum, these arguments show that if unawareness of functional deficits 
such as olfaction is proposed as representing a unique measure to predict cognitive decline, 
more general information on these aspects of meta-cognition in normal aging individuals is 
needed to be able to evaluate their contribution to detect normal and eventually pathological 
processes in aging.   
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The process of odor identification and its association with cognitive measures   
Paper 4 examined the odor identification process and its association with measures of 
cognitive function. Even though the data collected are not extensive enough to address the 
general difficulties associated with odor identification, they may provide some usable 
information. Results demonstrated that familiarity, cued and free identification are closely 
related to each other. Furthermore, the finding that the individual tasks correlated with a 
varying number of cognitive measures strengthens a common notion that free odor 
identification is the most difficult task, if difficulty is equated with the number of cognitive 
functions involved. A more speculative hypothesis would be that free odor identification, by 
showing to be associated with the largest number of cognitive functions, includes the most 
elaborated network of cognitive functioning. Results from neuroimaging studies support the 
idea of varying networks being involved in olfactory processing (Royet et al., 1999; 2001; 
Savic et al., 2000). These studies demonstrate different patterns of activation depending on 
the demands of the tasks, and Savic et al. suggested that olfactory processing seems to be 
organized in both a parallel and hierarchical fashion. 
The finding that both cued and free identification were strongest related to a measure 
of episodic memory is in agreement with earlier studies (Swan & Carmelli, 2002; Wilson et 
al., 2006). Even though it remains speculative, it seems reasonable that based on this close 
connection, odor identification is sensitive to changes in episodic memory function. This 
could further support the notion of some authors that odor identification performance could be 
a valuable adjunct in the assessment of elderly individuals in the risk of AD. However, 
longitudinal studies with strict inclusion criteria are necessary to investigate trajectories of 
performance in different olfactory tasks to be able to further understand the interrelation of 
sensory and cognitive variables. The results are insofar noteworthy as odor identification has 
been described as relying on semantic knowledge (de Wijk et al., 1995). Based on findings 
demonstrating that odor identification/naming often contains individual information, Herz and 
Eich (1995) argued that odors are retained in “personal meaning-associative networks” and 
may therefore also be of episodic and not only semantic nature.  
In this study, the amount of variance unaccounted for is notable. This suggests that 
other factors are likely to be important for odor identification performance. Larsson et al. 
(2005) found that sensory factors, in particular quality discrimination but also odor sensitivity, 
explained a large amount of age-related variance in identification ability. Thus, a more 
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extensive assessment of olfactory functioning could possibly have added important 
information. This concern is further strengthened by two recent studies showing that olfactory 
tests supplement each other and increase the reliability of olfactory diagnosis in early stages 
of olfactory dysfunction (Lötsch, Reichman, & Hummel, 2008; Djodjevic et al., 2008).  
 
General considerations 
A general concern to a more extensive assessment of olfactory functioning is the 
assessment of other causes for olfactory dysfunction. We used a self-report questionnaire to 
outline potential factors influencing olfactory functioning. However, based on these data it is 
not possible to definitely exclude other causes for an olfactory deficit. To be able to use 
olfactory performance as predictors for cognitive functioning or decline, a careful 
examination of the upper respiratory system and an individual’s medical history should be 
taken into account to obtain clinically reliable results. 
Another concern is that all papers included in this thesis are cross-sectional. It is 
known that results from this kind of studies may be confounded by cohort differences such as 
level of education, socioeconomic status, or cultural factors (Hofer & Sliwinski, 2001). Thus, 
age-related differences may be overestimated. On the contrary, longitudinal studies may 
underestimate age-related changes due to practice effects and attrition. However, the results 
presented in paper 1, 3, and 4 stress the advantage of longitudinal designs to follow-up 
impaired individuals (paper 1) or to be able to further examine olfactory and cognitive 
changes (paper 3 and 4). Furthermore, recruitment methods may have influenced our results. 
In paper 2-4, samples were drawn from a larger project on cognitive aging where the 
participants were self-recruited. This might have caused an overrepresentation of high 
performing adults. It must also be acknowledged that even though the focus in this thesis has 
been directed towards olfactory dysfunction and the early detection of AD, other 
neurodegenerative diseases are accompanied by olfactory dysfunction, e.g. Parkinson’s 
disease (Haehner et al., 2007) or dementia of vascular type (Gray et al., 2001). Finally, the 
association of ApoE ε4 and olfactory dysfunction was addressed in the introduction but no 
results concerning this issue were reported in any of the studies. This was due to the fact that 
no significant results were found when running the analyses.   
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Concluding remarks 
In sum, this thesis strengthens the contribution of neuropsychological assessment in 
elderly individuals in combination with other risk factors for AD, i.e. ApoE ε4, to describe 
individual differences of cognitive impairment. The findings on olfactory functioning 
assessed by means of an odor identification tasks emphasizes the contribution of this method 
in the neuropsychological assessment of aging individuals. 
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